Gates Foundation

Gates Foundation

Philanthropic foundation funding global health and development

Overview

Gates Foundation is a philanthropic organization funding efforts to reduce poverty, disease, and inequity worldwide, working through grants to nonprofits, governments, and research institutions rather than delivering services directly. Its funding spans maternal and child health, infectious disease elimination including malaria, TB, HIV, and polio, smallholder farmer development, and women's economic empowerment, spread across thousands of active grants. What sets Gates Foundation apart is its selective, proactive grantmaking: staff invite organizations to submit proposals, run Grand Challenges competitions, and publish grant data and financials openly. The goal is to give every person, regardless of where they are born, the chance to live a healthy, productive life.

About Gates Foundation

Simplify's Rating
Why Gates Foundation is rated
B+
Rated A on Competitive Edge
Rated A on Growth Potential
Rated C on Differentiation

Industries

Social Impact

Healthcare

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Seattle, Washington

Founded

2000

Get referred to Gates Foundation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Aug. 2026, Gates pledged up to $35M for ProFound's preeclampsia target discovery.
  • Aug. 2026, Gates funded Civitas ID and India AI agriculture tools expansion.
  • 2026's $9B budget and women’s health push keep hiring and program momentum strong.

What critics are saying

  • The 2045 shutdown accelerates succession risk as Mark Suzman cuts 500 jobs.
  • Epstein-related scrutiny keeps distracting leadership and donors, threatening partnerships through 2026.
  • Heavy bets on experimental AI platforms like ProFound expose results to failure by 2028.

What makes Gates Foundation unique

  • Aug. 2026, Gates pledged $540M to IHME, funding global health data infrastructure.
  • The foundation backs AI in health and agriculture, from ProFound Therapeutics to India.
  • Its 2045 wind-down forces unusually aggressive, mission-driven capital deployment across global health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Paid Family Leave

401(k) Retirement Plan

Remote Work Options

Hybrid Work Options

Flexible Work Hours

Wellness Program

Mental Health Support

Conferences Attendance Budget

Professional Development Budget

Stock Options

Company Equity

Reimbursement

Phone/Internet Stipend

Home Office Stipend

Relocation Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Gym Membership

Commuter Benefits

Meal Benefits

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Professional Development Budget

Company News

GenomeWeb
Aug 27th, 2026
Readily Diagnostics wins $970K Gates Foundation grant for STI testing.

Readily Diagnostics wins $970K Gates Foundation grant for STI testing. NEW YORK - Readily Diagnostics announced on Thursday that it has been awarded $970,000 from the Gates Foundation to support the Sweden-based startup's development of a sexually transmitted infections test for use at the point of care in low-resource settings. Get the full story with GenomeWeb Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month Already a GenomeWeb member? LoginLogin

EU-Startups
Aug 27th, 2026
Readily Diagnostics raises $916,000 from Gates Foundation for affordable STI test

Swedish point-of-care diagnostics company Readily Diagnostics has received a €811,000 grant from the Gates Foundation to develop an affordable test for chlamydia, gonorrhoea and trichomoniasis. The funding will support early concept and feasibility work, including sample preparation, antimicrobial resistance detection and product development planning. Founded in 2022 as a spin-out from Uppsala University, Readily develops rapid diagnostic testing for infectious diseases. The company's platform uses padlock-probe technology to deliver molecular diagnostic results without central laboratories. The test will run directly on patient samples and is designed for primary care, family planning and HIV-prevention settings. It will also detect genetic markers of antibiotic resistance in gonorrhoea, helping clinicians choose appropriate treatments.

Third News
Aug 27th, 2026
Gates Foundation invests $35M in ProFound Therapeutics for preeclampsia research

ProFound Therapeutics, a Cambridge, Massachusetts-based company, has secured up to $35 million from the Bill & Melinda Gates Foundation to advance maternal healthcare research. The initial $20 million investment will support ProFound's ProFoundry™ platform, which focuses on discovering drug targets and biomarkers for preeclampsia and eclampsia. The platform uses advanced protein detection methods and AI-driven analysis to identify novel proteins in the placenta and serum of affected women. This approach aims to create diagnostic tools and personalised treatment options for these pregnancy-related conditions, which remain chronically underdiagnosed and undertreated. CEO John Lepore noted that therapeutic options for these devastating conditions are currently limited, and the expanded proteome represents an untapped resource for developing groundbreaking therapies.

TechFace Group
Aug 27th, 2026
Gates Foundation, India to develop AI tools for farmers, explore Asia-Africa expansion.

Gates Foundation, India to develop AI tools for farmers, explore Asia-Africa expansion. The Economic Times Technology Aug 27, 2026 Synopsis The Gates Foundation will collaborate with India to enhance AI-powered digital tools for farmers. Discussions focused on India's advanced use of artificial intelligence and digital public infrastructure in agriculture. These tools will offer...

Resonate Group Incorporated
Aug 26th, 2026
Flagship's ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact.

Flagship's ProFound partners with Gates Foundation in $35M preeclampsia target discovery pact. * August 26, 2026 Flagship Pioneering's ProFound Therapeutics is keeping its string of high-profile partnerships going, forging a new pact with the Gates Foundation worth up to $35 million to find new drug targets for a dangerous pregnancy complication.

Recently Posted Jobs

Sign up to get curated job recommendations

Gates Foundation is Hiring for 18 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →